Antimicrobial Stewardship (Developments in Emerging and Existing Infectious Diseases, vol. 2)
Developments in Emerging and Existing Infectious Diseases Series, Vol. 2

Auteur :

Langue : Anglais

153,10 €

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

Ajouter au panierAjouter au panier
Date de parution :
Ouvrage 367 p. · Broché
Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.

The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.

With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A ‘hands on’, practical approach,  tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.

Section A: The Global Picture of Antimicrobial Use and Resistance
. Chapter 1: The Global Crisis of Antimicrobial Resistance
. Chapter 2: Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance
. Chapter 3: Quality Indicators and Quantity Metrics of Antibiotic Use

Section B: AMS Strategies
. Chapter 4: Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods
. Chapter 5: Education of Healthcare Professionals on Responsible Antimicrobial Prescribing
. Chapter 6: Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
. Chapter 7: Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy
. Chapter 8: The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs
. Chapter 9: The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship
. Chapter 10: The Role of Pharmacists
. Chapter 11: The Roles of Nurses in Antimicrobial Stewardship
. Chapter 12: Antifungal Stewardship

Section C: AMS in Specific Clinical Settings
. Chapter 13: Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care
. Chapter 14: Antimicrobial Stewardship: What to Tell the Patients and the General Public
. Chapter 15: Antimicrobial Stewardship in Long-Term Care Facilities
. Chapter 16: Antimicrobial Stewardship in ICU
. Chapter 17: Antimicrobial Stewardship in Hematology Patients
. Chapter 18: AMS in an Era of Multidrug-Resistant Bacteria

Section D: AMS Experiences Around the World
. Chapter 19.1: AMS Initiatives and Policies: The International Picture
. Chapter 19.2: Missions and Objectives of EUCIC and ESGAP
. Chapter 19.3: Antimicrobial Stewardship in Latin America
. Chapter 19.4: Antimicrobial Stewardship in Australia
. Chapter 19.5: Antimicrobial Stewardship in Austria
. Chapter 19.6: Antimicrobial Stewardship in Belgium
. Chapter 19.7: Antimicrobial Stewardship in Bulgaria
. Chapter 19.8: Antimicrobial Stewardship in Croatia
. Chapter 19.9: Antimicrobial Stewardship in England
. Chapter 19.10: Antimicrobial Stewardship in France
. Chapter 19.11: Antimicrobial Stewardship in Germany
. Chapter 19.12: Antimicrobial Stewardship in Greece
. Chapter 19.13: Antimicrobial Stewardship in India
. Chapter 19.14: Antimicrobial Stewardship in Israel
. Chapter 19.15: Antimicrobial Stewardship in Italy
. Chapter 19.16: Antimicrobial Stewardship in Japan
. Chapter 19.17: Antibiotic Stewardship in the Netherlands
. Chapter 19.18: Antimicrobial Stewardship in Scotland
. Chapter 19.19: Antimicrobial Stewardship in Slovenia
. Chapter 19.20: Antimicrobial Stewardship in South Africa
. Chapter 19.21: Antimicrobial Stewardship in Argentina
. Chapter 19.22: Antimicrobial Stewardship in Spain
. Chapter 19.23: Antibiotic Stewardship in Sweden
. Chapter 19.24: Antimicrobial Stewardship in Switzerland
. Chapter 19.25: Antimicrobial Stewardship in Turkey
. Chapter 19.26: Antimicrobial Stewardship in the United States

Section E: Research and Perspectives
. Chapter 20: Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: “Through Measuring to Knowledge”
Céline Pulcini is Full Professor of Infectious Disease in Nancy, France. Her main research interest lies in antimicrobial stewardship and vaccination practices with the aim of preventing the emergence of bacterial resistance to antibiotics. Professor Pulcini is Secretary of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antibiotic Policies. She is or has recently served also as Expert for the National Antibiotic Plan of the French Ministry of Health, the ECDC and the WHO. She is a member of the Executive Committee of the French Infectious Diseases Society (SPILF) and she coordinates the SPILF Antimicrobial Stewardship working group. In addition to this, Professor Pulcini is a partner in the European Innovative Medicines Initiative project ‘DRIVE-AB’. She received in 2017 the ESCMID Young Investigator Award.